ClinicalTrials.gg
CompletedNCT04382742Updated May 11, 2020

Exercise Response on Dose Curve Among Class I Obese Young Adult Population

An interventional study of Dynamic Resistance Exercises in Obesity, sponsored by Ziauddin University. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-11.

Sponsored by Ziauddin University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Dec 2019, registered May 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Not applicable
Ages
20 Years to 40 Years
Sex
All
01

Study summary

The study is aimed to determine impact of dynamic resistance exercise training on Body Fat percentage of class-I Obese population and to quantify the dose of exercise program using a probit regression curve

Read the detailed description

Methodology

A sample size of 34 participants 17 male and 17 female of aged between 20-40 years with class-I obesity were selected and recruited in this study. All the participants were initially screened using a physical activity and readiness questionnaire to determine if they are fit to perform exercises afterwards intervention based on dynamic exercises were given to the patient for 12 weeks based on the guidelines of American College of Sports Medicine and the quantification of exercises was done using a Frequency, Intensity, Time and Type (FITT) protocol. The training session was based on Warm up 5 to 10 minutes followed by conditioning phase of 20 minutes and a cool down phase of 5 to 10 minutes. The detailed description of each of the phase is as under:

Warm up Phase Dynamic light aerobic warm up exercises were performed by the participants for 5 to 10 minutes before the start of the conditioning. Two different exercises that were performed included i) High Knee in which the knees will be lifted as high as possible in such a manner that both feet should be at one time be above the ground ii) Jumping Jack Exercise in which a simultaneous movement of upper and lower limb will be performed in a manner that every time during a jump the arms were thrusted over the head while the foot moved out to the side and than returning back to the original position 10 repetitions of both the exercises were performed.

Dynamic Resistance Exercise Modified Wingate protocol that incorporates 20 minutes of training on a cycle ergometer; included one minute of cycling with resistance to be performed at 85% to 90% of Maximal Heart Rate (MHR) followed by one minute of cycling with no resistance. The protocol will be performed for 10 times for a duration of 20 minute of workout.

Cool Down The process of cool down last for 5-10 minutes. During this low intensity, long hold stretching were performed of lower limb and upper limb that included shoulder, calf and hamstring stretch

02

Conditions studied

  • Obesity

Browse trials for

03

In context

Obesity

6,583 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's enrollment of 34 is below the median of 77 across 5,091 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Ziauddin University is the lead sponsor of 51 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Class I obese population BMI 30 -39.9

      • Young adults of age 20-40 years
      • Male and female population

Exclusion criteria

Exclusion Criteria:

    • Recent surgery that limits participation in exercise program

      • Known Cardia Disease
      • Any comorbidity that limits participation in training program
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Exercise

    Behavioral: Dynamic Resistance Exercises

Interventions

  • BehavioralDynamic Resistance Exercises

    Modified Wingate protocol that incorprates 20 minutes of training on a cycle ergometer; included one minute of cycling with resistance to be performed at 85% to 90% of Maximal Heart Rate (MHR) followed by one minute of cycling with no resistance. The protocol will be performed for 10 times for a duration of 20 minute of workout.

06

What researchers measure

Primary outcomes

  1. Body Fat Percentage (Pre treatment)

    Body fat percentage is used to measure fat mass with higher percentage revealing greater body fat. The values are calculated using skin fold thickness (precision caliper) method.

    Time frame: Baseline

  2. Body Fat Percentage (Post treatment)

    Body fat percentage is used to measure fat mass with higher percentage revealing greater body fat. The values are calculated using skin fold thickness (precision caliper) method.

    Time frame: After 12 weeks of training

07

Study locations

1 site
  • Ziauddin University
    Karachi, Sindh, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2019 to primary completion in Mar 2020, 2 months.

Of 2,256 non-industry interventional studies with no phase under Obesity, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's 2 months is below that.

Counting every sponsor, half of 2,355 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2020
First posted
May 11, 2020
StartActual
Dec 15, 2019
Primary completionActual
Mar 1, 2020
CompletionActual
Apr 15, 2020
Last update
May 11, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04382742
Lead sponsor
Ziauddin University
Responsible party
Batool Hassan (Principal Investigator, Ziauddin University) — Principal investigator
First posted
May 11, 2020
Start date
Dec 15, 2019
Primary completion
Mar 1, 2020
Completion
Apr 15, 2020
Last update
May 11, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion